Work

Abstract PS3-08-04: Dalpiciclib Combined with Letrozole as Neoadjuvant Therapy for Stage II-III HR-Positive, HER2-Negative Breast Cancer: A Phase II Study

Year: 2026

Type: conference-abstract

Source: Clinical Cancer Research

DOI: 10.1158/1557-3265.sabcs25-ps3-08-04

Authors: Y. Mao, H. Wang, W. Li, T. Ma, X. Gao, W. Cao, X. Wang, Z. Niu, J. Cui, H. Hu, C. Liu, D. Jiang, G. Nie, C. Liu, X. Sun

Institutions: Qingdao University, Affiliated Hospital of Qingdao University

Language: English

Topic: Advanced Breast Cancer Therapies

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W7130700099

Cites:

Cited by:

Related to: